Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Aranda E, Cervantes A, Dorta J, Blanco E, Fernández-Martos C, Cruz-Hernandez JJ, Carrato A, Gonzalez-Mancha R, García-Conde J, Díaz-Rubio E. Aranda E, et al. Among authors: cervantes a. Cancer. 1995 Aug 15;76(4):559-63. doi: 10.1002/1097-0142(19950815)76:4<559::aid-cncr2820760404>3.0.co;2-o. Cancer. 1995. PMID: 8625147 Clinical Trial.
Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Aranda E, Cervantes A, Carrato A, Fernández-Martos C, Antón-Torres A, Massutí T, Barneto I, García-Conde J, Barón JM, Díaz-Rubio E. Aranda E, et al. Among authors: cervantes a. Ann Oncol. 1996 Aug;7(6):581-5. doi: 10.1093/oxfordjournals.annonc.a010674. Ann Oncol. 1996. PMID: 8879371 Free article. Clinical Trial.
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study.
Aranda E, Díaz-Rubio E, Cervantes A, Antón-Torres A, Carrato A, Massutí T, Tabernero JM, Sastre J, Trés A, Aparicio J, López-Vega JM, Barneto I, García-Conde J. Aranda E, et al. Among authors: cervantes a. Ann Oncol. 1998 Jul;9(7):727-31. doi: 10.1023/a:1008282824860. Ann Oncol. 1998. PMID: 9739438 Free article. Clinical Trial.
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Cervantes A, Villar-Grimalt A, Abad A, Antón-Torres A, Belón J, Dorta J, Tres A, Camps C, Fonseca E, Massutí B, et al. Cervantes A, et al. Ann Oncol. 1993 Nov;4(9):753-7. doi: 10.1093/oxfordjournals.annonc.a058660. Ann Oncol. 1993. PMID: 8280656 Free article. Clinical Trial.
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Díáz-Rubio E, Sastre J, Abad A, Navarro M, Aranda E, Carrato A, Gallén M, Marcuello E, Rifá J, Massuti T, Cervantes A, Antón A, Fernández Martos C. Díáz-Rubio E, et al. Among authors: cervantes a. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):35-40. Oncology (Williston Park). 1999. PMID: 10442357 Free article. Clinical Trial.
Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II study.
Antón A, Aranda E, Carrato A, Marcuello E, Massutti B, Cervantes A, Abad A, Sastre J, Fenández-Martos C, Gallén M, Díaz-Rubio E, Huarte L, Balcells M; TTD cooperative group. Antón A, et al. Among authors: cervantes a. Methods Find Exp Clin Pharmacol. 2003 Oct;25(8):639-43. doi: 10.1358/mf.2003.25.8.778085. Methods Find Exp Clin Pharmacol. 2003. PMID: 14671682 Free article. Clinical Trial.
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer.
Aranda E, Carrato A, Cervantes A, Sastre J, Gómez MA, Abad A, Masutti B, Ribera F, Marcuello E, Pronk L, Balcells M, Díaz-Rubio E; Grupo Español de Traitamiento de Tumores Digestivos. Aranda E, et al. Among authors: cervantes a. Ann Oncol. 2004 Apr;15(4):559-67. doi: 10.1093/annonc/mdh158. Ann Oncol. 2004. PMID: 15033659 Free article. Clinical Trial.
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.
Díaz-Rubio E, Gómez-España A, Massutí B, Sastre J, Reboredo M, Manzano JL, Rivera F, Safont MJ, Montagut C, González E, Benavides M, Marcuello E, Cervantes A, Martínez de Prado P, Fernández-Martos C, Arrivi A, Bando I, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Díaz-Rubio E, et al. Among authors: cervantes a. PLoS One. 2012;7(10):e47345. doi: 10.1371/journal.pone.0047345. Epub 2012 Oct 12. PLoS One. 2012. PMID: 23174912 Free PMC article. Clinical Trial.
610 results